A propensity score-matched analysis to evaluate the benefit of adjuvant therapy on disease recurrence of esophageal squamous cell carcinoma after R0 esophagectomy
After adjusting for baseline characteristics, AT tended to improve RFS after R0 esophagectomy in Chinese patients, with significant benefit associated with a higher PS score. The utility of PS to guide patient selection for AT in clinical practice needs further investigation.
Authors
- Chengqiang Li (ORCID: https://orcid.org/0000-0002-8549-2416)
- Hong Qiu
- Qingqing Hu (ORCID: https://orcid.org/0000-0003-2820-9490)
- Yuan Zhou (ORCID: https://orcid.org/0000-0003-4413-7490)
- Yuqin Cao (ORCID: https://orcid.org/0000-0003-0127-7557)
- Yajie Zhang (ORCID: https://orcid.org/0000-0002-3439-2773)
- Hecheng Li (ORCID: https://orcid.org/0000-0001-8069-6033)
- Yongjing Zhang (ORCID: https://orcid.org/0009-0004-4284-8138)
Institutions
- Johnson & Johnson (United States) (US)
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Johnson & Johnson (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/jtd-24-806
- Primary Topic
- Statistical Methods in Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Society of Clinical Oncology
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- Program of Shanghai Academic Research Leader